We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+22.84%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.3%
AUM
$1.59B
AUM Growth
-$22.5M
(-1.4%)
Cap. Flow
-$179M
Cap. Flow
% of AUM
-11.29%
Top 10 Holdings %
Top 10 Hldgs %
7.3%
Holding
2,269
New
605
Increased
523
Reduced
559
Closed
577
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Northrop Grumman
NOC
|
+$5.95M |
| 2 |
TJX Companies
TJX
|
+$5.66M |
| 3 |
Medtronic
MDT
|
+$5.07M |
| 4 |
JHG
Janus Henderson
JHG
|
+$4.86M |
| 5 |
Essential Properties Realty Trust
EPRT
|
+$4.56M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$28M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$22.8M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$20M |
| 4 |
State Street SPDR Bloomberg High Yield Bond ETF
JNK
|
+$12.5M |
| 5 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$8.13M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.05% |
| 2 | Financials | 14.8% |
| 3 | Technology | 14.7% |
| 4 | Industrials | 13.56% |
| 5 | Consumer Discretionary | 10.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Freightos
CRGO
$54.2M
| $33K | ﹤0.01% |
+21,916
| New | +$40K |
|
1677
Caesarstone
CSTE
$104M
| $31K | ﹤0.01% |
14,615
-24,550
| -63% | -$40.3K |
|
1678
Conduent
CNDT
$253M
| $30K | ﹤0.01% |
20,418
-133,683
| -87% | -$208K |
|
1679
Brilliant Earth
BRLT
$23.7M
| $26K | ﹤0.01% |
22,691
+9,025
| +66% | +$11.5K |
|
1680
Purple Innovation
PRPL
$11.1M
| $26K | ﹤0.01% |
+2,960
| New | +$36.3K |
|
1681
HF Foods Group
HFFG
$86.2M
| $24K | ﹤0.01% |
16,842
-68,093
| -80% | -$132K |
|
1682
Village Farms International
VFF
$382M
| $24K | ﹤0.01% |
11,924
-78,540
| -87% | -$196K |
|
1683
Westwater Resources
WWR
$67.2M
| $21K | ﹤0.01% |
42,014
-4,808
| -10% | -$2.85K |
|
1684
CalciMedica
CALC
$11.9M
| $18K | ﹤0.01% |
3,494
-1,261
| -27% | -$4.47K |
|
1685
BioCardia
BCDA
$16.2M
| $16K | ﹤0.01% |
+12,862
| New | +$13.6K |
|
|
MSGY
1686
Masonglory Ltd
MSGY
$4.18M
| $16K | ﹤0.01% |
4,031
+2,484
| +161% | +$9.89K |
|
1687
Curis
CRIS
$2.13M
| $12K | ﹤0.01% |
+1,138
| New | +$11.7K |
|
1688
VistaGen Therapeutics
VTGN
$13.1M
| $12K | ﹤0.01% |
54,584
+4,742
| +10% | +$2.86K |
|
1689
ESS Tech
GWH
$13.7M
| $10K | ﹤0.01% |
11,045
-134,533
| -92% | -$134K |
|
1690
Werewolf Therapeutics
HOWL
$47.7M
| $10K | ﹤0.01% |
+27,146
| New | +$16.5K |
|
1691
Biofrontera
BFRI
$17.8M
| $9K | ﹤0.01% |
+10,022
| New | +$9.91K |
|
1692
Cheche Group
CCG
$32.4M
| $8K | ﹤0.01% |
+436
| New | +$9.35K |
|
1693
Applied Optoelectronics
AAOI
$8.58B
| – | – |
-3,838
| Closed | -$325K |
|
1694
Apple
AAPL
$4.9T
| – | – |
-7,646
| Closed | -$1.94M |
|
|
AAT
1695
American Assets Trust
AAT
$1.32B
| – | – |
-20,862
| Closed | -$384K |
|
1696
AbbVie
ABBV
$468B
| – | – |
-5,116
| Closed | -$1.11M |
|
1697
Ambev
ABEV
$44.9B
| – | – |
-56,922
| Closed | -$166K |
|
1698
Arcosa
ACA
$7.2B
| – | – |
-8,489
| Closed | -$901K |
|
1699
Archer Aviation
ACHR
$4.4B
| – | – |
-136,936
| Closed | -$708K |
|
1700
American Coastal Insurance
ACIC
$429M
| – | – |
-16,283
| Closed | -$183K |
|
Similar funds
W
SW
PIS
ACM
CCP
FWP
NMC
LLL
GSA Capital Partners's Q2 2026 Portfolio in Review
As of Q2 2026, GSA Capital Partners held 2,269 positions worth $1.59B, down 1.4% from $1.61B the previous quarter. Its ten largest holdings account for 7.3% of the portfolio.
GSA Capital Partners withdrew a net $179M in Q2 2026, closing 577 positions and reducing 559 holdings. Its most notable exit was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $28M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 13% a quarter earlier, followed by Financials and Technology.
Against the trend, GSA Capital Partners opened a new position in Northrop Grumman worth $5.25M.
- GSA Capital Partners's largest Q2 2026 buy was Northrop Grumman: 10,314 shares worth $5.25M.
- GSA Capital Partners added most to TJX Companies in Q2 2026, an estimated $5.66M increase.
- GSA Capital Partners's biggest Q2 2026 reduction was Vanguard Intermediate-Term Corporate Bond ETF, cutting an estimated $20M.
- GSA Capital Partners fully exited iShares iBoxx $ Investment Grade Corporate Bond ETF in Q2 2026, selling an estimated $28M.
- GSA Capital Partners's ten largest holdings make up 7.3% of its $1.59B portfolio in Q2 2026.
- GSA Capital Partners opened 605 new positions and closed 577 in Q2 2026.
- GSA Capital Partners's portfolio value fell 1.4% quarter-over-quarter to $1.59B.
Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.